Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial

Autor: Schweighardt, Becky, Tompkins, Troy, Lau, Kelly, Jesaitis, Lynne, Qi, Yulan, Musson, Donald G., Farmer, Pamela, Haller, Christine, Shaywitz, Adam J., Yang, Ke, O’Neill, Charles A.
Zdroj: In Clinical Therapeutics 1 May 2015 37(5):1012-1021
Databáze: ScienceDirect